Vizgen to merge with Ultivue.

Vizgen, a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, agreed to merge with Ultivue, a provider of multiplex proteomic biomarker detection and advanced AI-driven spatial tissue profiling. Financial terms were not disclosed. The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified solutions in spatial multi-omics.